$NEO 8-K SEC Filings

Filed On	Filing
05 Oct 2026	8-K: Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers +1 more FORT MYERS, Fla.—NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that as part of a planned succession its Board of Dire...
11 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
28 Jul 2026	8-K: Results of Operations and Financial Condition
20 Jul 2026	8-K: Regulation FD Disclosure; Other Events
25 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
22 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
17 Jun 2026	8-K: Other Events
15 Jun 2026	8-K: Other Events
22 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
28 Apr 2026	8-K: Results of Operations and Financial Condition
17 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
30 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
28 Oct 2025	8-K: Results of Operations and Financial Condition
08 Aug 2025	8-K: Departure/Election of Directors or Officers; Compensation
29 Jul 2025	8-K: Results of Operations and Financial Condition
24 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
27 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
29 Apr 2025	8-K: Results of Operations and Financial Condition
08 Apr 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

Comments